prednisone has been researched along with Osteoporotic Fractures in 7 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Osteoporotic Fractures: Breaks in bones resulting from low bone mass and microarchitectural deterioration characteristic of OSTEOPOROSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Steps to prevent or treat osteoporosis should be considered in all patients who take the equivalent of prednisone at a dose of 2." | 5.05 | Glucocorticoid-induced osteoporosis: Insights for the clinician. ( Hayat, S; Magrey, MN, 2020) |
| "Prednisone doses were calculated at the end of the fourth year of follow-up (prednisone-4)." | 1.40 | Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus. ( Cabezas-Rodriguez, I; Medina, JA; Moran, MA; Ruiz-Arruza, I; Ruiz-Irastorza, G; Ugarte, A, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Sapkota, S | 1 |
| Baig, S | 1 |
| Hess, T | 1 |
| O'Connell, AM | 1 |
| Menk, J | 1 |
| Shyne, M | 1 |
| Fazeli, P | 1 |
| Ensrud, K | 1 |
| Shmagel, A | 1 |
| Hayat, S | 1 |
| Magrey, MN | 1 |
| Malochet-Guinamand, S | 1 |
| Lambert, C | 1 |
| Gossec, L | 1 |
| Soubrier, M | 1 |
| Dougados, M | 1 |
| Ruiz-Arruza, I | 1 |
| Ugarte, A | 1 |
| Cabezas-Rodriguez, I | 1 |
| Medina, JA | 1 |
| Moran, MA | 1 |
| Ruiz-Irastorza, G | 1 |
| Ritter, A | 1 |
| Burow, A | 1 |
| Vallelian, F | 1 |
| Schaer, D | 1 |
| Leib, ES | 1 |
| Winzenrieth, R | 1 |
| Tsang-A-Sjoe, MW | 1 |
| Bultink, IE | 1 |
| Heslinga, M | 1 |
| Voskuyl, AE | 1 |
2 reviews available for prednisone and Osteoporotic Fractures
| Article | Year |
|---|---|
Glucocorticoid-induced osteoporosis: Insights for the clinician.
Topics: Adult; Bone Density; Cancellous Bone; Drug Administration Schedule; Female; Glucocorticoids; Humans; | 2020 |
[Systemic glucocorticoids: diagnosis, prophylaxis and treatment of side effects].
Topics: Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Femoral Neck Fractures | 2014 |
1 trial available for prednisone and Osteoporotic Fractures
| Article | Year |
|---|---|
Evaluation of the Implementation of Guidelines on the Treatment of Osteoporosis in Patients with Rheumatoid Arthritis.
Topics: Aged; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Cross-Sectional Studies | 2020 |
4 other studies available for prednisone and Osteoporotic Fractures
| Article | Year |
|---|---|
Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care?
Topics: Adult; Bone Density Conservation Agents; Diphosphonates; Female; Glucocorticoids; Humans; Lupus Eryt | 2020 |
Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.
Topics: Adult; Cataract; Cohort Studies; Diabetes Mellitus; Female; Glucocorticoids; Humans; Lupus Erythemat | 2014 |
Bone status in glucocorticoid-treated men and women.
Topics: Absorptiometry, Photon; Adult; Aged; Anthropometry; Bone Density; Case-Control Studies; Female; Gluc | 2016 |
Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
Topics: Adult; Arthritis; Cataract; Cohort Studies; Diabetes Mellitus; Disease Progression; Female; Glucocor | 2017 |